There is a lot of evidence on the disparities in cancer care, but less on how to take those findings and turn them into actionable items to address the problem, said Karen Winkfield, MD, PhD, executive director of the Meharry-Vanderbilt Alliance.
There is a lot of evidence on the disparities in cancer care, but less on how to take those findings and turn them into actionable items to address the problem, said Karen Winkfield, MD, PhD, executive director of the Meharry-Vanderbilt Alliance.
Transcript
There is more research on disparities in health, and cancer specifically, but is the data and research actionable for providers, health systems, and policy makers?
So, there is a growing body of literature that actually speaks to what we're calling implementation science. How do you do things in a different way that actually can impact the health and the well-being of communities?
My colleagues and I were very honored to publish an article earlier in January of this year that provided an actionable framework for how to reduce cancer disparities. And it was a broad sweeping article that looked at the different components of cancer care. One of the things that we did was we talked to experts around the country about what they were doing. What are some of the things that they were doing that are actionable that we perhaps could share with the rest of the nation?
And so, we know that the cancer care continuum has several leaky areas where people fall through—whether it be from screening, prevention, treatment—and so we pulled that together in that article that really helps to outline an actionable framework.
Beyond that, there are some folks who are doing work that is, again, really driven towards what are the things that we can do versus just doing the descriptive work, which we know—we've been describing the problems in terms of cancer disparities for decades. It's time to do something. We do need more.
But there are some data that's out there around some actionable items. We just need to do more of that work.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More